Literature DB >> 33247420

Decline of coronary heart disease mortality is strongly effected by changing patterns of underlying causes of death: an analysis of mortality data from 27 countries of the WHO European region 2000 and 2013.

Susanne Stolpe1,2, Bernd Kowall3, Andreas Stang3,4.   

Abstract

Mortality rates for coronary heart disease (CHD) experience a longstanding decline, attributed to progress in prevention, diagnostics and therapy. However, CHD mortality rates vary between countries. To estimate whether national patterns of causes of death impact CHD mortality, data from the WHO "European detailed mortality database" for 2000 and 2013 for populations aged ≥ 80 years was analyzed. We extracted mortality rates for total mortality, cardiovascular diseases, neoplasms, dementia and ill-defined causes. We calculated proportions of selected causes of death among all deaths, and proportions of selected cardiovascular causes among cardiovascular deaths. CHD mortality rates were recalculated after re-coding ill-defined causes of death. Association between CHD mortality rates and proportions of CHD deaths was estimated by population-weighted linear regression. National patterns of causes of death were divers. In 2000, CHD was assigned as cause of death in 13-53% of all cardiovascular deaths. Until 2013, this proportion changed between - 65% (Czech Republic) and + 57% (Georgia). Dementia was increasingly assigned as underlying cause of death in Western Europe, but rarely in eastern European countries. Ill-defined causes accounted for between < 1% and 53% of all cardiovascular deaths. CHD mortality rates were closely linked to a countries' proportion of cardiovascular deaths assigned to CHD (R2 = 0.95 for 2000 and 0.99 for 2013). We show that CHD mortality is considerably influenced by national particularities in certifying death. Changes in CHD mortality rates reflect changes in certifying competing underlying causes of death. This must be accounted for when discussing reasons for the CHD mortality decline.

Entities:  

Keywords:  Causes of death; Coronary heart disease mortality; Mortality patterns; Mortality registry data

Year:  2020        PMID: 33247420     DOI: 10.1007/s10654-020-00699-0

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  28 in total

1.  Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations.

Authors:  H Tunstall-Pedoe; D Vanuzzo; M Hobbs; M Mähönen; Z Cepaitis; K Kuulasmaa; U Keil
Journal:  Lancet       Date:  2000-02-26       Impact factor: 79.321

2.  Relations of changes in coronary disease rates and changes in risk factor levels: methodological issues and a practical example.

Authors:  A Dobson; B Filipiak; K Kuulasmaa; R Beaglehole; A Stewart; M Hobbs; R Parsons; U Keil; E Greiser; H Korhonen; J Tuomilehto
Journal:  Am J Epidemiol       Date:  1996-05-15       Impact factor: 4.897

3.  Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994.

Authors:  S Capewell; C E Morrison; J J McMurray
Journal:  Heart       Date:  1999-04       Impact factor: 5.994

4.  Absence of Coronary Artery Calcification in Middle-Aged Familial Hypercholesterolemia Patients Without Atherosclerotic Cardiovascular Disease.

Authors:  Reed Mszar; Gowtham R Grandhi; Javier Valero-Elizondo; Salim S Virani; Ron Blankstein; Michael Blaha; Pedro Mata; Marcio H Miname; Khalid Al Rasadi; Harlan M Krumholz; Raul D Santos; Khurram Nasir
Journal:  JACC Cardiovasc Imaging       Date:  2019-11-11

Review 5.  Decline in Cardiovascular Mortality: Possible Causes and Implications.

Authors:  George A Mensah; Gina S Wei; Paul D Sorlie; Lawrence J Fine; Yves Rosenberg; Peter G Kaufmann; Michael E Mussolino; Lucy L Hsu; Ebyan Addou; Michael M Engelgau; David Gordon
Journal:  Circ Res       Date:  2017-01-20       Impact factor: 17.367

6.  Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002.

Authors:  Lena Björck; Annika Rosengren; Kathleen Bennett; George Lappas; Simon Capewell
Journal:  Eur Heart J       Date:  2009-01-13       Impact factor: 29.983

7.  Estimating the effect of long-term physical activity on cardiovascular disease and mortality: evidence from the Framingham Heart Study.

Authors:  Susan M Shortreed; Anna Peeters; Andrew B Forbes
Journal:  Heart       Date:  2013-03-08       Impact factor: 5.994

8.  Explaining the decline in coronary heart disease mortality rates in the Slovak Republic between 1993-2008.

Authors:  Marek Psota; Piotr Bandosz; Eva Gonçalvesová; Mária Avdičová; Mária Bucek Pšenková; Martin Studenčan; Jarmila Pekarčíková; Simon Capewell; Martin O'Flaherty
Journal:  PLoS One       Date:  2018-01-10       Impact factor: 3.240

9.  Explaining the decrease in U.S. deaths from coronary disease, 1980-2000.

Authors:  Earl S Ford; Umed A Ajani; Janet B Croft; Julia A Critchley; Darwin R Labarthe; Thomas E Kottke; Wayne H Giles; Simon Capewell
Journal:  N Engl J Med       Date:  2007-06-07       Impact factor: 91.245

10.  Analysing recent socioeconomic trends in coronary heart disease mortality in England, 2000-2007: a population modelling study.

Authors:  Madhavi Bajekal; Shaun Scholes; Hande Love; Nathaniel Hawkins; Martin O'Flaherty; Rosalind Raine; Simon Capewell
Journal:  PLoS Med       Date:  2012-06-12       Impact factor: 11.069

View more
  3 in total

Review 1.  Efficacy and Safety of Different Courses of Tongxinluo Capsule as Adjuvant Therapy for Coronary Heart Disease after Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Jiaqi Hui; Rong Yuan; Pengqi Li; Qiqi Xin; Yu Miao; Xiaoxu Shen; Fengqin Xu; Weihong Cong
Journal:  J Clin Med       Date:  2022-05-25       Impact factor: 4.964

2.  Test-Retest Reliability of the Coronary Heart Disease Damp Phlegm and Blood Stasis Pattern Questionnaire: Results from a Multicenter Clinical Trial.

Authors:  Ge Fang; Yaxin Wang; Zhenqian Yan; Xiaowen Zhou; Xingyu Fan; Xiaoqian Liao; Zhixi Hu; Xiantao Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-11-16       Impact factor: 2.629

3.  Interleukin 32 participates in cardiomyocyte-induced oxidative stress, inflammation and apoptosis during hypoxia/reoxygenation via the NOD2/NOX2/MAPK signaling pathway.

Authors:  Yuanyuan Li; Zhongyan Wang
Journal:  Exp Ther Med       Date:  2022-07-12       Impact factor: 2.751

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.